WellPoint Inc (WLP): Today's Featured Health Services Laggard

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

WellPoint ( WLP) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day down 0.2%. By the end of trading, WellPoint fell $1.16 (-1.8%) to $61.85 on average volume. Throughout the day, 2.3 million shares of WellPoint exchanged hands as compared to its average daily volume of 2.6 million shares. The stock ranged in price between $61.60-$62.85 after having opened the day at $62.79 as compared to the previous trading day's close of $63.01. Other companies within the Health Services industry that declined today were: Ironwood Pharmaceuticals ( IRWD), down 7.4%, Mela ( MELA), down 6.6%, LCA-Vision ( LCAV), down 6.4%, and CombiMatrix Corporation ( CBMX), down 5.7%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

WellPoint, Inc., through its subsidiaries, operates as a health benefits company in the United States. The company offers various network-based managed care plans to large and small employer, individual, Medicaid, and senior markets. WellPoint has a market cap of $18.96 billion and is part of the health care sector. The company has a P/E ratio of 8.2, below the S&P 500 P/E ratio of 17.7. Shares are up 2.5% year to date as of the close of trading on Tuesday. Currently there are seven analysts that rate WellPoint a buy, one analyst rates it a sell, and 10 rate it a hold.

TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

On the positive front, Unilife Corporation ( UNIS), up 12.8%, USMD Holdings ( USMD), up 11.1%, ERBA Diagnostics ( ERB), up 10.2%, and AtriCure ( ATRC), up 6.9%, were all gainers within the health services industry with DaVita HealthCare Partners ( DVA) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing